Exscientia Enters Broad Rare Disease Drug Discovery Collaboration with Rallybio
Joint venture will initiate drug discovery programs targeting rare diseases using AI Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery...
Do you have news for the Scottish Life Sciences Community?
Submit Your Own News